Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?

被引:4
|
作者
Galindo-Mendez, Brahyan [1 ]
Mayor, Luis C. [2 ]
Velandia-Hurtado, Fernando [1 ]
Calderon-Ospina, Carlos [1 ]
机构
[1] Univ Rosario, Sch Med & Hlth Sci, Dept Basic Sci, Bogota, Colombia
[2] Univ Los Andes, Hosp Univ Fdn Santa Bogot, Fac Med, Bogota, Colombia
来源
关键词
Epilepsy; Malformations of cortical development; Cortical dysplasia-focal epilepsy syndrome; Anticonvulsants; Drug resistance;
D O I
10.1016/j.ebcr.2015.03.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed atmaximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presentedwith focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment. (C) 2015 The Authors. Published by Elsevier Inc.
引用
收藏
页码:6 / 8
页数:3
相关论文
共 50 条
  • [41] Childhood epilepsy: What is the evidence for what we think and what we do?
    Camfield, P
    Camfield, C
    JOURNAL OF CHILD NEUROLOGY, 2003, 18 (04) : 272 - 287
  • [42] Shorebirds ingest plastics too: what we know, what we do not know, and what we should do next
    Flemming, Scott A.
    Lanctot, Richard B.
    Price, Courtney
    Mallory, Mark L.
    Kuhn, Susanne
    Drever, Mark C.
    Barry, Tom
    Provencher, Jennifer F.
    ENVIRONMENTAL REVIEWS, 2022, 30 (04): : 537 - 551
  • [43] What we do, what we should do, and what we should not do
    Ernst, E
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2001, 7 (04) : 36 - +
  • [44] What we claim to do and what we really do - a discrepancy in heart failure treatment
    Assmus, Birgit
    Sossalla, Samuel
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (06) : 1419 - 1422
  • [45] What place do carbamazepine-related antiepileptic drugs have in the modern day treatment of epilepsy?
    Lattanzi, Simona
    Belcastro, Vincenzo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1655 - 1658
  • [46] Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?
    Walczak, T
    DRUG SAFETY, 2003, 26 (10) : 673 - 683
  • [47] Do Antiepileptic Drugs Play a Role in Sudden Unexpected Death in Epilepsy?
    Thaddeus Walczak
    Drug Safety, 2003, 26 : 673 - 683
  • [48] WHAT DO WE PAY FOR COMPOUNDED DRUGS?
    Lin, T.
    Tran, D. M.
    Shoair, O. A.
    Huang, W.
    Cao, V
    Wilson, L.
    VALUE IN HEALTH, 2016, 19 (07) : A818 - A818
  • [49] CONTROLLING FOR MENTAL-HEALTH IN EARNINGS EQUATIONS - WHAT DO WE GAIN AND WHAT DO WE LOSE
    SAVOCA, E
    HEALTH ECONOMICS, 1995, 4 (05) : 399 - 410
  • [50] Racial/ethnic disparities in the treatment of epilepsy: What do we know? What do we need to know?
    Szaflarski, Magdalena
    Szaflarski, Jerzy P.
    Privitera, Michael D.
    Ficker, David M.
    Horner, Ronnie D.
    EPILEPSY & BEHAVIOR, 2006, 9 (02) : 243 - 264